Venlafaxine

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

EFFEXOR XR – Pfizer Canada Inc. (NOC Search)

Patents:

1248540: TEVA, RATIOPHARM, TEVA
2126305: RATIOPHARM
2134038: RATIOPHARM
2157186: RATIOPHARM
2167999: RATIOPHARM
2199778: RATIOPHARM, TEVA, RATIOPHARM, PHARMASCIENCE, COBALT, TEVA

COBALT

Infringement – T-804-09
PM(NOC) – T-1663-06

PHARMASCIENCE

Infringement – T-306-08

RATIOPHARM

PM(NOC) – A-194-07 (2007 FCA 264, 2007 FCA 361) – T-243-06 (2007 FC 340)

TEVA

Appeal – A-186-17 – A-417-11 (2012 FCA 141) – A-422-14 (2016 FCA 161, 2016 FCA 218) – A-486-11

TEVA, RATIOPHARM

Section 8 – T-1844-07 (2011 FC 1169, 2011 FC 1442, 2017 FC 526, 2017 FC 610, 2014 FC 248, 2014 FC 634)

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property